Skip to main content
TipRanks
Go Ultimate75% OFF

Scandinavian ChemoTech AB Class B (NEEMS.B) Ratios

1 Followers

Scandinavian ChemoTech AB Class B Ratios

SE:NEEMS.B's free cash flow for Q1 2026 was kr-1.14M. For the 2026 fiscal year, SE:NEEMS.B's free cash flow was increased by kr0.00 and operating cash flow was kr-1.14M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.911.051.881.537.10
Quick Ratio0.630.600.821.135.91
Cash Ratio0.370.130.240.764.59
Solvency Ratio-0.61-1.83-5.47-2.95-9.35
Operating Cash Flow Ratio-0.37-1.78-4.75-2.55-10.13
Short-Term Operating Cash Flow Coverage0.000.000.000.00-361.94
Net Current Asset Valuekr -876.00Kkr 370.00Kkr 3.36Mkr 4.11Mkr 11.54M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio4.142.241.351.551.08
Debt Service Coverage Ratio-2.22-10.51-13.96-11.94-24.31
Interest Coverage Ratio-3.24-10.86-14.42-11.02-25.30
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.080.050.100.190.08
Net Debt to EBITDA0.850.080.050.280.51
Profitability Margins
Gross Profit Margin-36.61%72.75%58.72%-11.63%659.18%
EBIT Margin-51.30%-190.97%-697.66%-4407.82%-34832.65%
EBITDA Margin-35.24%-188.49%-693.80%-4399.15%-34746.94%
Operating Profit Margin-51.30%-194.88%-717.12%-4421.14%-34851.02%
Pretax Profit Margin-65.58%-208.91%-747.38%-4808.88%-36210.20%
Net Profit Margin-65.58%-208.91%-747.38%-4808.88%-36210.20%
Continuous Operations Profit Margin-65.58%-208.91%-747.38%-4808.88%-36210.20%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT127.83%107.20%104.22%108.77%103.90%
Return on Assets (ROA)-61.03%-102.52%-141.85%-104.82%-68.74%
Return on Equity (ROE)-252.86%-229.38%-191.20%-162.56%-74.19%
Return on Capital Employed (ROCE)-197.80%-213.98%-183.46%-149.46%-71.40%
Return on Invested Capital (ROIC)-197.80%-213.98%-183.46%-149.46%-72.83%
Return on Tangible Assets-85.59%-172.76%-284.25%-185.30%-129.90%
Earnings Yield-6.68%-32.83%-63.93%-47.05%-12.52%
Efficiency Ratios
Receivables Turnover4.591.871.260.160.08
Payables Turnover9.051.260.490.29-0.27
Inventory Turnover6.010.540.290.17-0.12
Fixed Asset Turnover103.241641.50235.1713.510.67
Asset Turnover0.930.490.190.020.00
Working Capital Turnover Ratio-48.563.520.760.060.01
Cash Conversion Cycle99.93580.63804.373096.783179.90
Days of Sales Outstanding79.51195.23290.242214.694834.39
Days of Inventory Outstanding60.76675.121263.872140.23-2998.59
Days of Payables Outstanding40.34289.71749.741258.14-1344.11
Operating Cycle140.27870.351554.114354.921835.79
Cash Flow Ratios
Operating Cash Flow Per Share-0.16-0.56-1.30-1.97-2.22
Free Cash Flow Per Share-0.17-0.57-1.35-2.00-2.58
Dividend Paid and CapEx Coverage Ratio-8.57-285.76-26.80-59.31-6.03
Capital Expenditure Coverage Ratio-8.57-285.76-26.80-59.31-6.03
Operating Cash Flow Coverage Ratio0.000.000.000.00-361.94
Operating Cash Flow to Sales Ratio-0.30-2.00-6.46-41.50-391.49
Free Cash Flow Yield-3.47%-31.57%-57.31%-41.29%-15.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-14.76-3.03-1.56-2.13-7.99
Price-to-Sales (P/S) Ratio9.826.3611.69102.222891.75
Price-to-Book (P/B) Ratio37.866.992.993.465.92
Price-to-Free Cash Flow (P/FCF) Ratio-28.84-3.17-1.74-2.42-6.34
Price-to-Operating Cash Flow Ratio-32.21-3.18-1.81-2.46-7.39
Price-to-Earnings Growth (PEG) Ratio0.350.050.05-0.190.59
Enterprise Value Multiple-27.01-3.30-1.64-2.04-7.82
Enterprise Value116.94M40.84M32.07M42.50M133.07M
EV to EBITDA-27.01-3.30-1.64-2.04-7.82
EV to Sales9.526.2211.3689.842715.65
EV to Free Cash Flow-27.96-3.10-1.70-2.13-5.95
EV to Operating Cash Flow-31.23-3.11-1.76-2.16-6.94
Tangible Book Value Per Share-0.030.020.260.461.36
Shareholders’ Equity Per Share0.130.260.791.402.76
Tax and Other Ratios
Effective Tax Rate0.000.000.00-0.08-0.04
Revenue Per Share0.510.280.200.050.01
Net Income Per Share-0.34-0.59-1.50-2.28-2.05
Tax Burden1.001.001.001.001.00
Interest Burden1.281.091.071.091.04
Research & Development to Revenue0.000.290.916.1556.61
SG&A to Revenue0.002.350.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.581.030.860.941.12

Currency in SEK